News

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.
While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...
Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
Weight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...